quinoline has been researched along with Brain Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Drača, D; Gozzi, M; Hey-Hawkins, E; Maksimović-Ivanić, D; Marković, M; Mijatović, S | 1 |
| Chen, TC; Cho, HY; Golden, EB; Hofman, FM; Louie, SG; Schönthal, AH | 1 |
| Chang, JG; Chang, YS; Chen, JC; Chen, YF; Chen, YL; Hsiao, PC; Lee, CC; Liao, HF; Tseng, CH; Tzeng, CC | 1 |
3 other study(ies) available for quinoline and Brain Neoplasms
| Article | Year |
|---|---|
Ruthenacarborane and Quinoline: A Promising Combination for the Treatment of Brain Tumors.
Topics: Animals; Antineoplastic Agents; Astrocytoma; Autophagic Cell Death; Brain Neoplasms; Cell Line, Tumor; Coordination Complexes; Humans; Quinolines; Rats; Ruthenium | 2021 |
Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors.
Topics: Animals; Antimalarials; Antineoplastic Agents; Apoptosis; Autophagy; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Endoplasmic Reticulum Stress; Gene Expression Regulation, Neoplastic; Glioma; Humans; Mice, Nude; Poly(ADP-ribose) Polymerases; Quinolines; Xenograft Model Antitumor Assays | 2015 |
TCH1036, a indeno[1,2-c]quinoline derivative, potentially inhibited the growth of human brain malignant glioma (GBM) 8401 cells via suppression of the expression of Suv39h1 and PARP.
Topics: Brain Neoplasms; Catalytic Domain; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Glioma; Humans; Methyltransferases; Molecular Docking Simulation; Oximes; Poly (ADP-Ribose) Polymerase-1; Quinolines; Repressor Proteins; RNA, Messenger | 2016 |